BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kruger D, Yako YY, Devar J, Lahoud N, Smith M. Inflammatory cytokines and combined biomarker panels in pancreatic ductal adenocarcinoma: Enhancing diagnostic accuracy. PLoS One 2019;14:e0221169. [PMID: 31415645 DOI: 10.1371/journal.pone.0221169] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Bhatia R, Bhyravbhatla N, Kisling A, Li X, Batra SK, Kumar S. Cytokines Chattering in Pancreatic Ductal Adenocarcinoma Tumor Microenvironment. Semin Cancer Biol 2022:S1044-579X(22)00077-3. [PMID: 35346801 DOI: 10.1016/j.semcancer.2022.03.021] [Reference Citation Analysis]
2 Robak P, Węgłowska E, Dróżdż I, Mikulski D, Jarych D, Ferlińska M, Wawrzyniak E, Misiewicz M, Smolewski P, Fendler W, Szemraj J, Robak T. Cytokine and Chemokine Profile in Patients with Multiple Myeloma Treated with Bortezomib. Mediators Inflamm 2020;2020:1835836. [PMID: 32587468 DOI: 10.1155/2020/1835836] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
3 Cowell TW, Valera E, Jankelow A, Park J, Schrader AW, Ding R, Berger J, Bashir R, Han HS. Rapid, multiplexed detection of biomolecules using electrically distinct hydrogel beads. Lab Chip 2020;20:2274-83. [PMID: 32490455 DOI: 10.1039/d0lc00243g] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
4 Kartikasari AER, Huertas CS, Mitchell A, Plebanski M. Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis. Front Oncol 2021;11:692142. [PMID: 34307156 DOI: 10.3389/fonc.2021.692142] [Reference Citation Analysis]
5 Tao X, Xiang H, Pan Y, Shang D, Guo J, Gao G, Xiao GG. Pancreatitis initiated pancreatic ductal adenocarcinoma: Pathophysiology explaining clinical evidence. Pharmacol Res 2021;168:105595. [PMID: 33823219 DOI: 10.1016/j.phrs.2021.105595] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Lu SW, Pan HC, Hsu YH, Chang KC, Wu LW, Chen WY, Chang MS. IL-20 antagonist suppresses PD-L1 expression and prolongs survival in pancreatic cancer models. Nat Commun. 2020;11:4611. [PMID: 32929072 DOI: 10.1038/s41467-020-18244-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]